Jason Norcross, MD
Adult Reconstructive Orthopaedic Surgery · Hickory, NCNPI 1104873454
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $35,545 of the $54,926 with a category attached, or 64.7%. Smith+Nephew accounts for 97.2% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $20,944 and has fallen 81.8% since, to $3,808 in 2025.
Across 118 payments — averaging $465.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$53K
- Stryker$1K
- Bard Access Systems, Inc.$87
- Zimmer Biomet$38
- Heron Therapeutics, Inc.$24
- Zimvie Inc.$22
- plus $85 from 5 others
What the payments were for
- Consulting fees$5,83511%
- Speaking & faculty fees$35,54565%
- Travel & lodging$9,41217%
- Food & beverage$4,1348%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 97 | $53,369 |
| Stryker | 11 | $1,300 |
| Bard Access Systems, Inc. | 1 | $87 |
| Zimmer Biomet | 2 | $38 |
| Heron Therapeutics, Inc. | 1 | $24 |
| Zimvie Inc. | 1 | $22 |
| Peerless Surgical Inc. | 1 | $21 |
| Bioventus LLC | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Convatec Inc. | 1 | $16 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$49,744
- REAL INTELLIGENCE$19,641
- BIRMINGHAM HIP$9,786
- CORI$8,988
- Anthology$6,240
- Journey II BCS$6,240
- Journey II CR$6,240
- Tandem$6,020
- NAVIO$5,777
- Navio Surgical System$4,587
- OR3O Dual Mobility$3,560
- RI.HIP NAVIGATION$3,410
- Journey PFJ$1,660
- Engage Partial Knee System$1,660
- POLARSTEM$1,660
- REDAPT$1,660
- MAKO$1,135
- Journey II XR$209
- OXINIUM Knee$209
- K-15 PORK$146
How this compares
Too few adult reconstructive orthopaedic surgery providers in North Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 318 | $5,370 |
| Tramadol Hcl | 122 | $769 |
| Methylprednisolone | 88 | $508 |
| Scopolamine | 13 | $392 |
| Oxycodone Hcl | 33 | $176 |
| Dexamethasone | 25 | $130 |
| Naproxen | 11 | $105 |
| Meloxicam | 43 | $86 |
| Cyclobenzaprine Hcl | 13 | $48 |
| Cephalexin | 16 | $21 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Hickory
- David PollockBermuda Run$4.8M
- Thorsten SeylerDurham$2.2M
- Adam BrekkeDurham$86K
- John ShieldsWinston Salem$78K
- Andrew SchwartzDurham$75K
- Eric DilboneMorrisville$28K
- Walter FruehWilmington$26K
- David CaseyPinehurst$20K
- Charles LongHendersonville$18K
- Bernard KemkerRocky Mount$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.